Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Kymera Therapeutics Announces $102 Million Series C Financing
Cambridge, Mass (March 12, 2020) – Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to invent breakthrough pr…
Ryvu Therapeutics receives Orphan Drug Designation from FDA
KRAKOW, Poland, March 28, 2020 – Ryvu Therapeutics (WSE: RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies th…
Affimed Announces FDA Granted Orphan Drug Designation
HEIDELBERG, Germany, April 1, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their inn…
Stemline Therapeutics to be Acquired by Menarini Group
FLORENCE, Italy and NEW YORK, May 04, 2020 - Menarini Group, a privately held Italian pharmaceutical and diagnostics company, and Stemline Therapeutic…
Media resources
Email
Contact us for inquiries and interview requests.
Press Kit
Explore details for journalists and media outlets.
Brand Center
Access approved logos, guidelines, and other assets.